Treatment of Ventricular Septal Defect (VSD)

Indications for VSD Closure

• The American College of Cardiology recommends VSD closure in adults with hemodynamically significant left-to-right shunt (Qp:Qs ≥1.5:1) and left ventricular volume overload when pulmonary artery systolic pressure is less than 50% of systemic pressure and pulmonary vascular resistance is less than one-third systemic resistance 1, 2
• The American College of Cardiology recommends VSD closure in symptomatic patients with heart failure symptoms attributable to left-to-right shunting, provided they don't have severe pulmonary vascular disease 3
• The American College of Cardiology recommends VSD closure in patients with a history of infective endocarditis caused by VSD 3
• The American College of Cardiology suggests that surgical closure of perimembranous or supracristal VSD is reasonable when progressive aortic regurgitation develops from VSD-associated aortic valve prolapse, with a strength of evidence classified as Class IIa 1, 2, 4, 3

Medical Management

• The American College of Cardiology recommends the use of ACE inhibitors for patients with aortic valve regurgitation and chronic heart failure symptoms, with a strength of evidence classified as Class I 3, 5
• The American College of Cardiology recommends the use of diuretics, such as furosemide, for volume management and pulmonary congestion, with a strength of evidence classified as Class I 3, 5
• The American College of Cardiology suggests the use of nitrates for symptom relief in patients without hypotension, with a strength of evidence classified as Class IIa 5

Observation Without Intervention

• The American College of Cardiology recommends conservative management with surveillance for small restrictive VSDs (Qp:Qs <1.5:1) with normal pulmonary pressures, with a 25-year survival rate of 96% 4, 6

Timing of Intervention

• The European Heart Journal recommends immediate IABP insertion with early surgical repair (within 3-9 days) for post-MI VSD rupture, achieving an 89% survival rate versus 92% first-year mortality without surgery 7

Follow-Up Protocol

• The American College of Cardiology recommends annual follow-up for patients with residual heart failure, residual shunts, pulmonary arterial hypertension, aortic regurgitation, or RV or LV outflow tract obstruction 8, 3
• The American College of Cardiology recommends surveillance echocardiography to assess the development of aortic or tricuspid regurgitation, degree of residual shunt, left ventricular function, pulmonary artery pressure, development of double-chambered right ventricle, and development of discrete subaortic stenosis 3

Critical Pitfalls to Avoid

• The American College of Cardiology warns against misdiagnosis of small VSDs, which may be mistaken for innocent murmurs, and recommends vigilant monitoring for complications such as aortic valve prolapse, double-chambered RV, or subaortic stenosis development 3
• The European Heart Journal recommends avoiding VSD closure in patients with Eisenmenger syndrome or exercise-induced desaturation 9, 3

VSD Closure Recommendation for High Flow, Low Resistance with Moderate Pulmonary Hypertension

Definitive Indication for Closure

• The American College of Cardiology recommends VSD closure for patients with a Qp:Qs ratio of 12:1, which far exceeds the threshold of ≥1.5:1 required for closure, and a PVR of 0.2 Wood units, which is dramatically below the critical threshold of <one-third systemic resistance 10, 11
• The "high flow, low resistance" pattern indicates significant left-to-right shunting with preserved pulmonary vascular bed reactivity, and the moderate pulmonary hypertension is flow-mediated rather than resistance-mediated, which is reversible after closure 12

Understanding Your "Moderate Pulmonary Hypertension"

• When PVR is <one-third systemic, elevated PA pressure reflects increased flow rather than irreversible vascular disease, and the ACC/AHA guidelines specifically permit closure when PA systolic pressure is <50% of systemic pressure with low PVR 10, 12
• This distinguishes patients from those with Eisenmenger physiology who have PVR >two-thirds systemic and are contraindicated for closure 10, 11

Surgical Approach Recommendation

• Surgical closure is the preferred method for VSD, and all VSD closures should be performed by surgeons with congenital heart disease expertise, with patch closure through a right atrial approach typically used 13

Critical Pre-Operative Considerations

• Evaluation for aortic valve prolapse and regurgitation is necessary, particularly if the patient has a perimembranous or supracristal VSD, as 6% develop progressive AR 12
• Associated muscular VSDs should be evaluated, as they may only manifest after closure of the dominant defect 13

Post-Operative Management Expectations

• Significant reduction in PA pressures is expected as the flow-mediated component resolves after closure 12
• Annual follow-up at an Adult Congenital Heart Disease center is required if residual issues develop, and every 3-5 years if complete closure with no residual shunt or complications 13

Absolute Contraindications That Do NOT Apply to You

• VSD closure would be contraindicated if the patient had PA systolic pressure >two-thirds systemic, PVR >two-thirds systemic, or net right-to-left shunt (Eisenmenger syndrome), but none of these apply to this case 10, 11, 12

Management of Asymptomatic Ventricular Septal Defects

Indications for Conservative Management

• The European Society of Cardiology guidelines specify that asymptomatic patients without left ventricular volume overload should not undergo surgery, even with a QP:QS ratio >1.5:1, as seen in this patient with a QP:QS ratio of 1.8:1 14
• A pulmonary arterial systolic pressure of 7.0 mmHg is dramatically below any threshold for concern, and guidelines specify intervention only when pulmonary pressures approach 50% of systemic pressure in the context of significant shunting 14
• The absence of symptoms is critical, and the European Society of Cardiology guidelines explicitly state that asymptomatic patients without LV volume overload should not undergo surgery, even with QP:QS >1.5:1 14

Surveillance Requirements

• Annual echocardiographic monitoring should assess development or progression of aortic regurgitation, particularly important if this is a perimembranous or supracristal VSD, as 6% develop progressive AR requiring intervention 14
• Left ventricular dimensions and systolic function should be monitored, as intervention becomes indicated if LV volume overload develops 14
• Pulmonary artery pressure trends should be assessed, though currently normal, serial assessment ensures no progression 14
• Development of double-chambered right ventricle (DCRV) should be monitored, which can occur as a late complication and may require intervention even with lower gradients 14, 15
• Tricuspid regurgitation severity should be assessed, as progressive TR can develop from the high-velocity VSD jet 14

Follow-Up Interval

• Given the asymptomatic status, normal LV size, and normal pulmonary pressures, evaluation every 3-5 years is reasonable rather than annual follow-up 14

Critical Pitfalls to Avoid

• The 107 mmHg gradient does not indicate need for intervention, as this is fundamentally different from outflow tract obstruction where gradients >64 mmHg warrant repair 15
• The 1.8:1 ratio must be accompanied by clinical or echocardiographic evidence of LV volume overload to justify closure in asymptomatic patients 14

Absolute Indications for Intervention

• Development of symptoms (dyspnea, fatigue, heart failure) attributable to the shunt 14
• Echocardiographic evidence of LV volume overload (increased LV end-diastolic dimension, reduced ejection fraction <55%) 14
• History of infective endocarditis caused by the VSD 14
• Progressive aortic regurgitation from aortic valve cusp prolapse (particularly relevant for perimembranous/supracristal VSDs) 14
• Development of DCRV, which is usually progressive and may require intervention even without other criteria 14, 15